Blog

Introduction Disease awareness is a cornerstone of proactive healthcare management, enabling early diagnosis, informed decision-making and improved patient outcomes. In the digital age, harnessing the expertise and influence of healthcare...

Introduction The journey of developing a new pharmaceutical drug is a complex and intricate process that involves rigorous research, clinical trials and regulatory approvals. Amidst these multifaceted stages, there comes...

Introduction The pre-marketing phase of a prescription drug is a critical juncture that sets the stage for a successful product launch and early adoption. One key element during this phase...

Curious? Schedule a meeting with us. Tip: involve your colleagues from other departments within your company. In this way we can instantly answer questions and provide clarity from various points...

A CRM application and a consent management platform are complementary solutions, developed with a different purpose. Every Pharma & life sciences company should be aware that a consent management platform...

Introduction The pharmaceutical industry relies heavily on the collection of opt-in data from healthcare professionals, particularly doctors, to gather valuable insights, conduct clinical trials and promote their products effectively. In...

OptInsight has been at the forefront of assisting organizations in achieving and maintaining GDPR compliance. Here's how OptInsight's suite of features has made an impact: Consent Management and Preference Center....

Introduction. It has been five years since the General Data Protection Regulation (GDPR) came into effect, revolutionizing data privacy and protection practices across various sectors, including pharmaceutical companies. As we...

Introduction In today's digital age, social media platforms have become powerful tools for connecting people from all walks of life. Among the of users are doctors, who are increasingly turning to...

In recent years, digital communication has become an increasingly important tool for pharmaceutical companies to engage with healthcare professionals (HCPs). However, the preferences of doctors for digital communication can vary...